Related Experiment Video
Updated: Aug 23, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates
Angelico D Aputen1, Maria George Elias1,2, Jayne Gilbert3
1School of Science, Western Sydney University, Locked Bag 1797, Sydney, NSW 2751, Australia.
New platinum(IV) complexes show potent anticancer activity, particularly against prostate and resistant ovarian cancer cells. Complexes 4 and 6, featuring fluoro- and bromo-phenylacetic acid ligands, demonstrate significant efficacy, outperforming cisplatin.
Area of Science:
- Medicinal Chemistry
- Inorganic Chemistry
- Cancer Biology
Background:
- Platinum-based drugs are mainstays in cancer chemotherapy.
- Development of novel platinum complexes is crucial to overcome drug resistance and improve efficacy.
Purpose of the Study:
- To synthesize and characterize novel platinum(IV) complexes with halogenated phenylacetic acid ligands.
- To evaluate the in vitro cytotoxicity of these complexes against a broad panel of human cancer cell lines, including drug-resistant variants.
Main Methods:
- Synthesis and characterization of platinum(IV) complexes using spectroscopic and spectrometric techniques.
- In vitro cytotoxicity assays (GI50 determination) on multiple cancer cell lines (colon, glioblastoma, breast, ovarian, lung, prostate, neuroblastoma, pancreas).
- Assessment of complex stability, solubility, lipophilicity, and reactive oxygen species production.
Main Results:
- Complexes 4 (4-fluorophenylacetic acid) and 6 (4-bromophenylacetic acid) exhibited superior cytotoxic activity.
- Complex 4 showed remarkable potency in Du145 prostate cancer cells (GI50 = 0.7 nM), significantly exceeding cisplatin and a lead complex.
- Complex 4 demonstrated high efficacy against an ADDP-resistant ovarian cancer cell line (GI50 = 6 nM), vastly outperforming cisplatin.
Conclusions:
- Novel platinum(IV) complexes possess significant in vitro anticancer potential.
- Complexes 4 and 6 are promising candidates for further investigation as anticancer agents, especially for resistant cancers.
- The halogenated phenylacetic acid ligands contribute to enhanced biological activity and potency.
Related Concept Videos
Valence Bond Theory
Complexation Equilibria: The Chelate Effect
EDTA: Chemistry and Properties
Complexometric Titration: Ligands
ortho–para-Directing Deactivators: Halogens
Electrophilic Aromatic Substitution: Chlorination and Bromination of Benzene

